CAD 0.32
(6.67%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.13 Million CAD | 57.39% |
2022 | 1.35 Million CAD | -54.88% |
2021 | 3 Million CAD | 1165.36% |
2020 | 237.32 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.89 Million CAD | 159.95% |
2023 Q1 | 710.75 Thousand CAD | 57.1% |
2023 FY | 2.13 Million CAD | 57.39% |
2023 Q4 | 726.29 Thousand CAD | 129.73% |
2023 Q2 | 464.06 Thousand CAD | -34.71% |
2023 Q3 | 316.14 Thousand CAD | -31.87% |
2022 Q1 | 452.42 Thousand CAD | -56.27% |
2022 Q4 | 452.42 Thousand CAD | 117.93% |
2022 Q3 | 207.59 Thousand CAD | -26.59% |
2022 FY | 1.35 Million CAD | -54.88% |
2022 Q2 | 282.79 Thousand CAD | -37.49% |
2021 Q3 | 1 Million CAD | 144.6% |
2021 Q1 | 425.83 Thousand CAD | 0.0% |
2021 Q4 | 1.03 Million CAD | 3.21% |
2021 FY | 3 Million CAD | 1165.36% |
2021 Q2 | 409.82 Thousand CAD | -3.76% |
2020 FY | 237.32 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AI/ML Innovations Inc. | 1.95 Million CAD | -8.809% |
Diagnamed Holdings Corp. | 1.17 Million CAD | -81.069% |
Pangenomic Health Inc. | 2.03 Million CAD | -5.026% |
nDatalyze Corp. | 381.76 Thousand CAD | -458.565% |
Treatment.Com International Inc. | 2.32 Million CAD | 8.361% |